Inovio Pharmaceuticals, Inc.
PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy
Last updated:
Abstract:
Disclosed herein is a vaccine comprising an antigen and PD1 antibody and/or PDL1 antibody. Also disclosed herein is a method for enhancing an immune response in a subject. The method may comprise administering the vaccine to the subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
6 Jan 2015
Issue date:
17 Nov 2020